$AIP

Alpern Paul L sold $450K of AIP

Alpern Paul L (VP and General Counsel) sold 12,502 shares of Arteris, Inc. (AIP) at an average of $36.02 ($35.98–$36.39, $0.45M total) across 2 trades on 2026-06-01 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Alpern Paul L
Published Jun 3, 2026, 9:43 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 28, 2026, 4:02 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$AIP
Bearish
medium confidence
Mentioned
$AIP
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AIPBearishLow
01

Why it matters

The disclosed sale adds transparency but is unlikely to move the stock significantly.

02

Market read

Small insider sale; limited trading relevance.

03

What to watch

Holding after sale remains sizable (80,384 shares), indicating continued confidence.

Relevance 3/10Novelty 3/10Timing: after-hours filing on June 3

Background

Arteris, a provider of IP for automotive and IoT chips, filed a Form 4 reporting an insider sale.

Company-level read

Ticker impact

$AIPBearishMedium confidence
Context

Form 4 filing shows VP/General Counsel sold 12,502 shares for $450K via 10b5‑1 plan.

Expected impact

potential modest pressure as market prices in insider sell

Evidence & confidence

Sale size is modest relative to float, but insider status and use of 10b5‑1 plan suggest possible downside bias.

Market effects

Minimal impact on semiconductor design sector.

No regional effect.

Limited to Arteris shareholders.

Counterpoint

Insider sale could be routine liquidity event, not a bearish signal.

Key entities

  • Arteris, Inc.

    Issuer of the Form 4 filing.

  • Paul L. Alpern

    VP and General Counsel, insider seller.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AIPMedAI 8/10

Arteris (AIP) Q2 2026 Earnings Call Transcript

Arteris, Inc. (AIP) reported Q2 2026 revenue of $24.1 million, up 46% year over year. ACV plus royalties were $99.5 million, up 44%, and remaining performance obligation was $135 million, up 36%. Cash and investments rose to $123 million after an at-the-market raise. Full-year 2026 revenue guidance was raised to $95-$98 million.

MedAI 8/10

Arteris Inc. raises FY26 sales guidance to $95-98M range

Arteris Inc. raised its FY2026 revenue guidance to $95.0 million to $98.0 million, up from $91.0 million to $95.0 million previously. The new range is above the $94.578 million analyst consensus estimate, reflecting stronger-than-expected demand for its NoC interconnects and design automation tools, according to the company.

$AIPHighAI 9/10

Arteris Announces Financial Results for the Second Quarter and Estimated Third Quarter and Updated Full Year 2026 Guidance

Arteris, Inc. (AIP) filed an SEC Form 8-K — Results of Operations and Financial Condition. Arteris Announces Financial Results for the Second Quarter and Estimated Third Quarter and Updated Full Year 2026 Guidance CAMPBELL, Calif. - August 6, 2026 - Arteris, Inc. (Nasdaq: AIP), a leading provider of semiconductor technology for accelerating innovation in the AI era, to